Inhibitors of SARM1 NADase activity and uses thereof
US11253503B2 · kind B2 · utility
0Cited by
1References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 22, 2017 |
| Grant date | Feb 22, 2022 |
| Priority date | — |
| Expiry date | Sep 22, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compounds useful as inhibitors of SARM1 NADase activity, compositions thereof, and methods of using the same. The present disclosure provides compounds useful for treating a neurodegenerative or neurological disease or disorder, compositions thereof, and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.